Kristian F. Humer's most recent trade in Foghorn Therapeutics Inc was a trade of 120,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 22, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Foghorn Therapeutics Inc | Kristian F. Humer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2025 | 120,000 | 120,000 | - | - | Stock Option (right to buy) | |
Sensei Biotherapeutics Inc | Kristian F. Humer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
Foghorn Therapeutics Inc | Kristian F. Humer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2024 | 275,000 | 275,000 | - | - | Stock Option (Right to buy) |